Both in Pharmaceuticals
Bicycle Therapeutics vs Quoin Pharmaceuticals
Over the past year BCYC returned −43.5% and QNRX returned −54.2%; their daily moves had a correlation of 0.15.
BCYC −43.5% QNRX −54.2%Growth of $1, one year, split-adjusted
| Metric | BCYC | QNRX |
|---|---|---|
| Price | $3.72 | $3.73 |
| Market cap | $260.4M | $17.9M |
| Today | −1.46% | −4.59% |
| 1 month | −2.2% | −14.5% |
| 6 months | −21.3% | −38.6% |
| Year to date | −47.5% | −74.2% |
| 1 year | −42.3% | −58.6% |
| Revenue growth (YoY) | +190.2% | — |
| Gross margin | 100.0% | — |
| Net margin | −30.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.1× | — |
| Net cash | $469.9M | $9.7M |
| Dividend yield | — | — |
| Volatility (60d) | 57.1% | 90.2% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).